CluePoints Announces Amit Patel as New CFO

Organizational changes support rapid growth, scale, and focus for RBQM leader

King of Prussia, PA – April 5^th, 2023: RBQM leader, CluePoints, has today announced that Amit Patel will join as the new Chief Financial Officer (CFO) amid ambitious growth plans and organizational changes as it continues to drive the paradigm shift in how world-class risk-based quality management (RBQM) and data quality oversight is delivered. With a projected outlook of a 25% increase in staff numbers, and a 35%+ increase in revenues in 2023, CluePoints is reorganizing for further growth, scale, and focus on achieving its goals.

Amit Patel is an experienced strategic and commercial SaaS CFO and entrepreneur who will work with the Leadership Team at CluePoints to take the business to the next level as a multi-national SaaS leader. Amit has many years of experience building and scaling SaaS companies through significant go-to-market expansion, continued professionalization of the organization through systems and people and corporate development via M&A where opportunities arise.   

CluePoints’ former VP of People, Celine Daubresse, will be promoted to Chief People Officer reporting to the CEO to provide increased focus on all people aspects as the company evolves and grows.

Francois Torche will lead a single, consolidated Product, Engineering, and Research organization to execute the product vision, strategy, and direction as CluePoints’ Chief Product & Technology Officer.

Commenting on the new developments, CluePoints CEO, Andy Cooper, said:

“While traditional Risk-Based Quality Management (RBQM) complements people and processes with data and technology, the future will look to AI and deep learning to further interrogate data and processes and enable improved risk assessment. CluePoints sees a huge opportunity for further growth as RBQM pushes boundaries even further into these areas and therefore has appointed the expertise of Amit Patel to capitalize on this opportunity as our CFO. We are, therefore, proactively scaling up and investing in the best talent, a world-class product portfolio, and strategic leadership to fulfill our ambitions and meet the extraordinary demand we are experiencing. It is an exciting time to be part of a world-class organization pushing the boundaries to support excellent clinical trial execution.”

For further information on CluePoints’ solutions and developments, please visit www.cluepoints.com

-END-

About CluePoints

CluePoints is the premier Risk-Based Quality Management (RBQM) and Data Quality Oversight Software provider. Our products utilize comprehensive statistical algorithms to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA, EMA, and ICH E6 (R2), CluePoints® is deployed to support central and on-site monitoring, medical review, quality risk management and to drive a holistic Risk-Based strategy in all trials. Coupled with thought leadership and consulting expertise to aid pre-study risk assessment, identification of risk controls and solution implementation you now have everything you need to adhere with global regulatory guidance. The result is increased operational efficiency, lower costs, and reduced regulatory submission risk as part of the industry paradigm shift to RBQM.